Skip to main content
Caplight Logo









Rejoovenate Bio

Rejoovenate Bio

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://rejoovenatebio.com/

Company Overview

Rejoovenate Bio operates in Healthcare & Life Sciences and is based in San Francisco, California. It was founded in 2025.

Rejoovenate Bio is a biotechnology company developing laboratory-based solutions to address age-related declines in egg quality and extend female reproductive healthspan.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Rejoovenate Bio Comparables

Compare Rejoovenate Bio with similar companies based on industry and business-model similarity.

Rejoovenate Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
U-Ploid Biotechnologies
87%
Gameto
83%
Vitra Labs
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Rejoovenate Bio Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Rejoovenate Bio. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Rejoovenate Bio Filings

Explore SEC and related filing metadata, where available.

Rejoovenate Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Rejoovenate Bio's valuation, stock price, and market status.

Is Rejoovenate Bio a public or private company?

Rejoovenate Bio is a private company.

What is the current stock price of Rejoovenate Bio?

Rejoovenate Bio is a private company, so its shares have no public market price. Caplight tracks Rejoovenate Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Rejoovenate Bio worth (valuation)?

Valuation information for Rejoovenate Bio is not publicly available.

Can I buy Rejoovenate Bio stock?

Rejoovenate Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Rejoovenate Bio's last funding round?

Funding round information for Rejoovenate Bio is not publicly available.

Who are the main investors in Rejoovenate Bio?

Investor information for Rejoovenate Bio is not publicly disclosed.

Will Rejoovenate Bio IPO soon?

No public IPO plans have been announced for Rejoovenate Bio.

How can I track Rejoovenate Bio secondary market activity?

Caplight tracks bids, offers, and trades in Rejoovenate Bio's shares on secondary markets.

Firmographic Details

HeadquartersSan Francisco, California
Year Founded2025
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?